Cholesterol-Lowering Antibody Evolocumab Cuts Heart Attack Risk in Landmark Analysis
A meta-analysis of nine randomised trials involving nearly 68,000 patients shows evolocumab dramatically lowers LDL cholesterol and reduces heart attacks ...
A meta-analysis of nine randomised trials involving nearly 68,000 patients shows evolocumab dramatically lowers LDL cholesterol and reduces heart attacks ...
A new PLOS Medicine Perspective argues that the widening gap between drug efficacy in trials and real-world effectiveness is driven ...
A multicenter Chinese randomized trial found that low-dose ticagrelor plus aspirin halved early neurological deterioration after high-risk minor stroke compared ...
A new framework published in Annals of Clinical and Translational Neurology proposes integrating community engagement and implementation science across the ...
A new meta-analysis of nearly 18,400 patients shows that central retinal artery occlusion carries a risk of new-onset atrial fibrillation ...
A 13-year UK cohort study of over 444,000 COPD patients found that atrial fibrillation incidence rose 33 percent and anticoagulant ...
A rigorous evaluation of China's first stroke meteorological warning system in Tianjin found it cut hospital admissions by nearly 7 ...
Atrial fibrillation (AF) represents one of the most prevalent cardiac arrhythmias, impacting millions of individuals worldwide. Patients diagnosed with AF ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine